Industry: Consumer Goods
Published Date: 2025-11-16
Pages: 110 Pages
Report ld: 5458987
Request Sample
Customized Report
The global Commercial Infant Formulas market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
By 2025, the evolving U.S. tariff policy is poised to inject considerable uncertainty into the global economic landscape. This report delves into the latest U.S. tariff measures and the corresponding policy responses across the globe, evaluating their impacts on Commercial Infant Formulas market competitiveness, regional economic performance, and supply chain configurations.
According to World Bank statistics, the global birth rate in 2021 was about 1.7%. Although the population growth rate had slowed down, with the development of the world economy and the increase of per capita disposable income of residents, the spending power is growing. Therefore, there is still a large room for development in the baby products industry. Improving product quality and tapping the value of a single customer will become the drivers for the growth of the infant and child industry. Refinement and diversification are the core characteristics of the consumer demand. China has a large population base, and even if the population growth rate slows down, there will still be a demographic dividend. The State Council in 2022 proposes to "Guide market players to produce safer and healthier domestic infant products". According to the National Bureau of Statistics, China"s birth rate in 2022 was 6.77%, and the birth population was 9.56 million. According to the results of the seventh national census in 2021, the number of infants and young children aged 0-6 in China reached 140 million, of which the number of infants and young children aged 3-6 exceeded 70 million. The huge population size has brewed a market demand with huge potential, and the children"s consumption market has risen rapidly. Chinese families spend a lot on childcare, with the average cost of childcare ranking second in the world. The survey data released by China Research Center for Children"s Industry shows that in 80% of families in China, children"s expenditures account for 30% to 50% of household expenditures, and the average annual consumption of children in families is ¥17,000 to 25,500. According to data from the Yuwa Population Research, the national average cost of raising a child (the cost of raising a child to the age of 18) is ¥485,218. From the perspective of specific stages, the largest proportion is the cost of raising children aged 6-14, accounting for about 45%. The cost during pregnancy, the cost of childbirth and confinement, and the cost of raising babies aged 0-2 accounted for 2.06%, 2.09% and 13.33% separately.
The global Commercial Infant Formulas market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2020-2031.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Commercial Infant Formulas market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Soy-based Formulas in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., 6-12 Month Infant in India).
Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
This is not just another market study. By fusing global trend analysis with hyper-local operational intelligence, we deliver:
- Risk-Controlled Market Entry: Navigate regulatory complexities in focus markets (e.g., China’s policies).
- Product Portfolio Optimization: Align offerings with regional preferences (e.g., Cow Milk Protein-based Formulas dominance in Europe vs. Soy-based Formulas demand in MEA).
- Competitor Counterstrategies: Decode player tactics in fragmented vs. consolidated markets.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Commercial Infant Formulas Product Scope
1.2 Commercial Infant Formulas by Type
1.2.1 Global Commercial Infant Formulas Sales by Type (2020 & 2024 & 2031)
1.2.2 Cow Milk Protein-based Formulas
1.2.3 Soy-based Formulas
1.2.4 Protein Hydrolysate Formulas
1.2.5 Others
1.3 Commercial Infant Formulas by Application
1.3.1 Global Commercial Infant Formulas Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 0-6 Month Infant
1.3.3 6-12 Month Infant
1.3.4 12-24 Month Infant
1.3.5 Others
1.4 Global Commercial Infant Formulas Market Estimates and Forecasts (2020-2031)
1.4.1 Global Commercial Infant Formulas Market Size in Value Growth Rate (2020-2031)
1.4.2 Global Commercial Infant Formulas Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global Commercial Infant Formulas Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global Commercial Infant Formulas Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global Commercial Infant Formulas Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global Commercial Infant Formulas Sales Market Share by Region (2020-2025)
2.2.2 Global Commercial Infant Formulas Revenue Market Share by Region (2020-2025)
2.3 Global Commercial Infant Formulas Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Commercial Infant Formulas Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Commercial Infant Formulas Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America Commercial Infant Formulas Market Size and Prospective (2020-2031)
2.4.2 Europe Commercial Infant Formulas Market Size and Prospective (2020-2031)
2.4.3 China Commercial Infant Formulas Market Size and Prospective (2020-2031)
2.4.4 Japan Commercial Infant Formulas Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global Commercial Infant Formulas Historic Market Review by Type (2020-2025)
3.1.1 Global Commercial Infant Formulas Sales by Type (2020-2025)
3.1.2 Global Commercial Infant Formulas Revenue by Type (2020-2025)
3.1.3 Global Commercial Infant Formulas Price by Type (2020-2025)
3.2 Global Commercial Infant Formulas Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Commercial Infant Formulas Sales Forecast by Type (2026-2031)
3.2.2 Global Commercial Infant Formulas Revenue Forecast by Type (2026-2031)
3.2.3 Global Commercial Infant Formulas Price Forecast by Type (2026-2031)
3.3 Different Types Commercial Infant Formulas Representative Players
4 Global Market Size by Application
4.1 Global Commercial Infant Formulas Historic Market Review by Application (2020-2025)
4.1.1 Global Commercial Infant Formulas Sales by Application (2020-2025)
4.1.2 Global Commercial Infant Formulas Revenue by Application (2020-2025)
4.1.3 Global Commercial Infant Formulas Price by Application (2020-2025)
4.2 Global Commercial Infant Formulas Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global Commercial Infant Formulas Sales Forecast by Application (2026-2031)
4.2.2 Global Commercial Infant Formulas Revenue Forecast by Application (2026-2031)
4.2.3 Global Commercial Infant Formulas Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in Commercial Infant Formulas Application
5 Competition Landscape by Players
5.1 Global Commercial Infant Formulas Sales by Players (2020-2025)
5.2 Global Top Commercial Infant Formulas Players by Revenue (2020-2025)
5.3 Global Commercial Infant Formulas Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Commercial Infant Formulas as of 2024)
5.4 Global Commercial Infant Formulas Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Commercial Infant Formulas, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Commercial Infant Formulas, Product Type & Application
5.7 Global Key Manufacturers of Commercial Infant Formulas, Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Commercial Infant Formulas Sales by Company
6.1.1.1 North America Commercial Infant Formulas Sales by Company (2020-2025)
6.1.1.2 North America Commercial Infant Formulas Revenue by Company (2020-2025)
6.1.2 North America Commercial Infant Formulas Sales Breakdown by Type (2020-2025)
6.1.3 North America Commercial Infant Formulas Sales Breakdown by Application (2020-2025)
6.1.4 North America Commercial Infant Formulas Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Commercial Infant Formulas Sales by Company
6.2.1.1 Europe Commercial Infant Formulas Sales by Company (2020-2025)
6.2.1.2 Europe Commercial Infant Formulas Revenue by Company (2020-2025)
6.2.2 Europe Commercial Infant Formulas Sales Breakdown by Type (2020-2025)
6.2.3 Europe Commercial Infant Formulas Sales Breakdown by Application (2020-2025)
6.2.4 Europe Commercial Infant Formulas Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Commercial Infant Formulas Sales by Company
6.3.1.1 China Commercial Infant Formulas Sales by Company (2020-2025)
6.3.1.2 China Commercial Infant Formulas Revenue by Company (2020-2025)
6.3.2 China Commercial Infant Formulas Sales Breakdown by Type (2020-2025)
6.3.3 China Commercial Infant Formulas Sales Breakdown by Application (2020-2025)
6.3.4 China Commercial Infant Formulas Major Customer
6.3.5 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Commercial Infant Formulas Sales by Company
6.4.1.1 Japan Commercial Infant Formulas Sales by Company (2020-2025)
6.4.1.2 Japan Commercial Infant Formulas Revenue by Company (2020-2025)
6.4.2 Japan Commercial Infant Formulas Sales Breakdown by Type (2020-2025)
6.4.3 Japan Commercial Infant Formulas Sales Breakdown by Application (2020-2025)
6.4.4 Japan Commercial Infant Formulas Major Customer
6.4.5 Japan Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 Nestle
7.1.1 Nestle Company Information
7.1.2 Nestle Business Overview
7.1.3 Nestle Commercial Infant Formulas Sales, Revenue and Gross Margin (2020-2025)
7.1.4 Nestle Commercial Infant Formulas Products Offered
7.1.5 Nestle Recent Development
7.2 Mead Johnson&Company,LLC
7.2.1 Mead Johnson&Company,LLC Company Information
7.2.2 Mead Johnson&Company,LLC Business Overview
7.2.3 Mead Johnson&Company,LLC Commercial Infant Formulas Sales, Revenue and Gross Margin (2020-2025)
7.2.4 Mead Johnson&Company,LLC Commercial Infant Formulas Products Offered
7.2.5 Mead Johnson&Company,LLC Recent Development
7.3 Abbott
7.3.1 Abbott Company Information
7.3.2 Abbott Business Overview
7.3.3 Abbott Commercial Infant Formulas Sales, Revenue and Gross Margin (2020-2025)
7.3.4 Abbott Commercial Infant Formulas Products Offered
7.3.5 Abbott Recent Development
7.4 Feihe
7.4.1 Feihe Company Information
7.4.2 Feihe Business Overview
7.4.3 Feihe Commercial Infant Formulas Sales, Revenue and Gross Margin (2020-2025)
7.4.4 Feihe Commercial Infant Formulas Products Offered
7.4.5 Feihe Recent Development
7.5 Yili
7.5.1 Yili Company Information
7.5.2 Yili Business Overview
7.5.3 Yili Commercial Infant Formulas Sales, Revenue and Gross Margin (2020-2025)
7.5.4 Yili Commercial Infant Formulas Products Offered
7.5.5 Yili Recent Development
7.6 Mengniu
7.6.1 Mengniu Company Information
7.6.2 Mengniu Business Overview
7.6.3 Mengniu Commercial Infant Formulas Sales, Revenue and Gross Margin (2020-2025)
7.6.4 Mengniu Commercial Infant Formulas Products Offered
7.6.5 Mengniu Recent Development
7.7 Biostime
7.7.1 Biostime Company Information
7.7.2 Biostime Business Overview
7.7.3 Biostime Commercial Infant Formulas Sales, Revenue and Gross Margin (2020-2025)
7.7.4 Biostime Commercial Infant Formulas Products Offered
7.7.5 Biostime Recent Development
7.8 Beingmate
7.8.1 Beingmate Company Information
7.8.2 Beingmate Business Overview
7.8.3 Beingmate Commercial Infant Formulas Sales, Revenue and Gross Margin (2020-2025)
7.8.4 Beingmate Commercial Infant Formulas Products Offered
7.8.5 Beingmate Recent Development
7.9 Synutra International Inc
7.9.1 Synutra International Inc Company Information
7.9.2 Synutra International Inc Business Overview
7.9.3 Synutra International Inc Commercial Infant Formulas Sales, Revenue and Gross Margin (2020-2025)
7.9.4 Synutra International Inc Commercial Infant Formulas Products Offered
7.9.5 Synutra International Inc Recent Development
7.10 Wondersun
7.10.1 Wondersun Company Information
7.10.2 Wondersun Business Overview
7.10.3 Wondersun Commercial Infant Formulas Sales, Revenue and Gross Margin (2020-2025)
7.10.4 Wondersun Commercial Infant Formulas Products Offered
7.10.5 Wondersun Recent Development
7.11 Wissun
7.11.1 Wissun Company Information
7.11.2 Wissun Business Overview
7.11.3 Wissun Commercial Infant Formulas Sales, Revenue and Gross Margin (2020-2025)
7.11.4 Wissun Commercial Infant Formulas Products Offered
7.11.5 Wissun Recent Development
7.12 Shijiazhuang Junlebao Dairy Co., Ltd.
7.12.1 Shijiazhuang Junlebao Dairy Co., Ltd. Company Information
7.12.2 Shijiazhuang Junlebao Dairy Co., Ltd. Business Overview
7.12.3 Shijiazhuang Junlebao Dairy Co., Ltd. Commercial Infant Formulas Sales, Revenue and Gross Margin (2020-2025)
7.12.4 Shijiazhuang Junlebao Dairy Co., Ltd. Commercial Infant Formulas Products Offered
7.12.5 Shijiazhuang Junlebao Dairy Co., Ltd. Recent Development
7.13 Brightdairy Dairy Co., Ltd
7.13.1 Brightdairy Dairy Co., Ltd Company Information
7.13.2 Brightdairy Dairy Co., Ltd Business Overview
7.13.3 Brightdairy Dairy Co., Ltd Commercial Infant Formulas Sales, Revenue and Gross Margin (2020-2025)
7.13.4 Brightdairy Dairy Co., Ltd Commercial Infant Formulas Products Offered
7.13.5 Brightdairy Dairy Co., Ltd Recent Development
7.14 Sanyuan Group
7.14.1 Sanyuan Group Company Information
7.14.2 Sanyuan Group Business Overview
7.14.3 Sanyuan Group Commercial Infant Formulas Sales, Revenue and Gross Margin (2020-2025)
7.14.4 Sanyuan Group Commercial Infant Formulas Products Offered
7.14.5 Sanyuan Group Recent Development
7.15 Yinqiao Group
7.15.1 Yinqiao Group Company Information
7.15.2 Yinqiao Group Business Overview
7.15.3 Yinqiao Group Commercial Infant Formulas Sales, Revenue and Gross Margin (2020-2025)
7.15.4 Yinqiao Group Commercial Infant Formulas Products Offered
7.15.5 Yinqiao Group Recent Development
7.16 Longdan Dairy
7.16.1 Longdan Dairy Company Information
7.16.2 Longdan Dairy Business Overview
7.16.3 Longdan Dairy Commercial Infant Formulas Sales, Revenue and Gross Margin (2020-2025)
7.16.4 Longdan Dairy Commercial Infant Formulas Products Offered
7.16.5 Longdan Dairy Recent Development
8 Commercial Infant Formulas Manufacturing Cost Analysis
8.1 Commercial Infant Formulas Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Commercial Infant Formulas
8.4 Commercial Infant Formulas Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Commercial Infant Formulas Distributors List
9.3 Commercial Infant Formulas Customers
10 Commercial Infant Formulas Market Dynamics
10.1 Commercial Infant Formulas Industry Trends
10.2 Commercial Infant Formulas Market Drivers
10.3 Commercial Infant Formulas Market Challenges
10.4 Commercial Infant Formulas Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Commercial Infant Formulas was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-06-16
Pages: 151
USD 3950.00
(Single User License)
The global Commercial Infant Formulas market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-19
Pages: 134
USD 2900.00
(Single User License)
The global Commercial Infant Formulas market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-16
Pages: 172
USD 4900.00
(Single User License)
The global market for Commercial Infant Formulas was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-07
Pages: 134
USD 3950.00
(Single User License)
The global market for Commercial Infant Formulas was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-07
Pages: 100
USD 2900.00
(Single User License)
The global market for Commercial Infant Formulas was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-11
Pages: 135
USD 3950.00
(Single User License)
The global market for Commercial Infant Formulas was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-06-16
Pages: 151
The global Commercial Infant Formulas market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-19
Pages: 134
The global Commercial Infant Formulas market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-16
Pages: 172
The global market for Commercial Infant Formulas was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-07
Pages: 134
The global market for Commercial Infant Formulas was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-07
Pages: 100
The global market for Commercial Infant Formulas was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-11
Pages: 135
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now